References
- Ahlenius I., Floberg J. and Thomassen P. (1995) Sixty-six cases of intrauterine fetal death: a prospective study with an extensive test protocol. Acta Obstetricia et Gynecologica Scandinavica, 74, 109–117.
- Branch D., Andres L., Digre K., Rote N. and Scott J. (1989) The association of antiphospholipid antibodies with severe pre-eclampsia. Obstetrics and Gynecology, 73, 541 —545.
- Cowchock F., Reece E., Balaban D., Branch D. and Plouffe L. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. American Journal of Obstetrics and Gynecology, 166, 1318— 1323.
- Creagh M. and Greaves M. (1991) Lupus anticoagulant. Blood Review, 5, 162— 167.
- Geis W. and Branch W. (2001) Obstetric implications of anti-phospholipid antibodies: pregnancy loss and other complica-tions. Clinical Obstetrics and Gynecology, 24, 2 — 10.
- Hadi H. and Treadwell E. (1990) Lupus anticoagulant and anticardiolipin antibodies in pregnancy: a review 11. Diag-nosis and management. Obstetrical and Gynecological Survey, 45, 786–791.
- Harris E. and Spinnato J. (1991) Should anticardiolipin tests be performed in otherwise healthy pregnant women? American Journal of Obstetrics and Gynecology, 165, 1272— 1277.
- Kutteh W. (1996) Antiphospholipid antibody-associated recur-rent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 1584— 1589
- Lockwood M., Romero M., Feinberg R., Clye L., Coster B. and Hobbins J. (1989) The prevalence and biologic sig-nificance of lupus anticoagulant and anticardiolipin anti-bodies in a general obstetric population. American Journal of Obstetrics and Gynecology, 161, 369–373.
- Lubbe W. and Liggins G. (1985) Lupus anticoagulant and pregnancy. American Journal of Obstetrics and Gynecology, 153, 322–327.
- Petri M., Rheinschmidt M., Whiting-O'Keefe Q., Hellman D. and Corash L. (1987) The frequency of lupus anticoagulant in systemic lupus erythematosus. Annals of Internal Medicine, 106, 524–531.
- Reece E., Gabrielli S., Cullen M., Zheng X., Hobbins J. and Harris E. (1990) Recurrent adverse pregnancy outcome and antiphospholipid antibodies. American Journal of Obstetrics and Gynecology, 163, 162— 169.
- Scott R. (1987) Anticardiolipin antibodies and pre-eclampsia. British Journal of Obstetrics and Gynaecology, 94, 604–605.
- Wharfe G., Fletcher H. and Reid M. (1999) The prevalence of lupus anticoagulant in Jamaican primiparae and the clinical significance in asymptomatic patients. West Indian Medical Journal, 44, 126–128.
- Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris EN., Hughes
- G.R., Triplett D.A. and Khamashta M.A. (1999) Interna-tional consensus statement on preliminary classification criteria for definite anti phospholipids syndrome: report of an international workshop. Arthritis Rheumatology, 42, 1309–1311.
- Yasuda M., Takakuwa K., Tokunaga A. and Tanaka K. (1995) Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecol-ogy, 86, 555–559.